Digestive issues are increasingly recognized as early signs of Parkinson’s disease, sometimes appearing years before the more well-known movement symptoms such as tremors and stiffness. A recent review in Integrative Medicine examines how gastrointestinal (GI) disturbances and the gut-brain axis may be linked to both the onset and progression of Parkinson’s disease (PD).
According to the review, about 70% to 80% of people with PD experience lower GI symptoms, which can significantly impact their quality of life even before a neurological diagnosis is made. These symptoms include chronic constipation, delayed bowel transit, and incomplete evacuation. Such digestive problems can also affect medication absorption—particularly levodopa—leading to inconsistent symptom control.
The gut-brain axis refers to a two-way communication system between the GI tract and central nervous system involving neural, immune, and metabolic pathways. The vagus nerve serves as a primary connection point between these systems. Research has found that abnormal alpha-synuclein protein aggregates—the hallmark of PD—can appear in the enteric nervous system years prior to motor symptoms developing.
“Lower levels of short-chain fatty acids (SCFAs), particularly butyrate, are commonly reported and may compromise gut barrier integrity, allowing inflammatory substances to enter the bloodstream and potentially influence the brain,” notes the review. “These processes are associated with, rather than proven causes of, neuroinflammation and neuronal injury and may help explain observed links between gut health and both motor and non-motor symptoms, including fatigue and cognitive decline, in people with PD.”
Gut dysbiosis—an imbalance in intestinal bacteria—is often present in those with PD. This imbalance can lead to increased production of pro-inflammatory microbial metabolites such as lipopolysaccharides. In addition, serotonin signaling is disrupted; since most serotonin is produced in the GI tract by enterochromaffin cells with regulation from gut bacteria, this disruption can further impair intestinal movement.
Chronic GI dysfunction is also linked to ongoing systemic inflammation. Increased permeability in the gut allows inflammatory molecules into circulation where they may cross into brain tissue via a compromised blood-brain barrier.
While these findings support what some call a “bottom-up” model—where pathological changes begin outside rather than inside the brain—the authors emphasize that GI dysfunction is just one part of a complex interplay involving genetic factors and environmental exposures.
The review points out that diet rich in fiber or following Mediterranean-style patterns could improve microbial diversity within the gut. Regular exercise supports motility while probiotics or prebiotics might offer additional benefit according to small clinical trials. However, interventions like fecal microbiota transplantation remain experimental at this stage.
“This review highlights the GI tract's important role in the early features and progression of PD,” state its authors. “Improving gut health through diet, lifestyle modifications, and microbiome-focused therapies may enhance symptom management and quality of life, but further research is required to determine whether these approaches can alter disease trajectory.”
Ongoing studies will be necessary for clarifying if correcting digestive imbalances can change outcomes for people affected by Parkinson’s disease.
